Devices › Device types
FDA product code GKT · class 2 · Hematology
Separator, automated, blood cell, diagnostic: medical device reports filed with FDA
6,581 reports carry this product code, 1993–2026; 6 brands with a page.
- 6,581
- reports with this product code
- 0% of all MAUDE reports
- 155
- reports, 12 months to August 2026
- 341 in the 12 months before
- 77.2%
- classified as malfunction
- 62.3% across all reports
- 4%
- classified as death, as reported
- 0.9% across all reports
Product code GKT is FDA's classification for "Separator, automated, blood cell, diagnostic" (hematology panel), a class 2 device. 6,581 medical device reports carry this product code, 0% of the MAUDE database, from May 1993 to August 2026.
155 reports arrived in the 12 months to August 2026, down 55% from 341 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (77.2%), injury (14.1%) and death (4%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Trima Accel | 4,240 | 89 | 0.2% | 93.1% |
| Spectra Optia | 397 | 70 | 4.9% | 56.3% |
| Cobe Spectra Blood Collection | 287 | 0 | 4.2% | 18.8% |
| Pcs2 Plasma Collection System | 264 | 0 | 28.8% | 59.1% |
| Trima Accel Enhanced Plt Pls Rbc Set | 49 | 0 | 0% | 79% |
| Baxter | 1 | 3 | 3.8% | 54.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Terumo Bct | 5,154 | 78.3% |
| Haemonetics | 545 | 8.3% |
| Baxter Healthcare | 376 | 5.7% |
| Terumo | 3 | 0% |
| Beckman Coulter | 2 | 0% |
| Gambro Healthcare | 2 | 0% |
| Fresenius USA | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| High test results | 1,333 | 20.3% |
| Insufficient device problem information | 1,173 | 17.8% |
| Device operates differently than expectedthe device behaved unexpectedly | 505 | 7.7% |
| High readingsreadings were too high | 258 | 3.9% |
| Mechanical problema mechanical problem | 165 | 2.5% |
| Device slipped | 150 | 2.3% |
| Device displays incorrect message | 143 | 2.2% |
| Improper or incorrect procedure or method | 142 | 2.2% |
| Disposable | 124 | 1.9% |
| Fluid/blood leak | 107 | 1.6% |
| Contamination of device ingredient or reagent | 106 | 1.6% |
| Reactiona reaction, type not specified | 91 | 1.4% |
| Thermal decomposition of device | 89 | 1.4% |
| Air leak | 84 | 1.3% |
| Incorrect or inadequate test results | 82 | 1.2% |
| Incorrect, inadequate or imprecise result or readings | 82 | 1.2% |
| Inaccurate flow rate | 77 | 1.2% |
| Device handling problem | 76 | 1.2% |
| Temperature problem | 67 | 1% |
| Patient-device incompatibilitythe device did not suit the patient | 64 | 1% |
Questions about separator, automated, blood cell, diagnostic reports
What is product code GKT?
FDA's classification code for "Separator, automated, blood cell, diagnostic", class 2, reviewed by the hematology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
6,581 reports through August 2026, 155 of them in the latest 12 months.
Which brands appear most often?
Trima Accel (4,240), Spectra Optia (397), Cobe Spectra Blood Collection (287), Pcs2 Plasma Collection System (264) and Trima Accel Enhanced Plt Pls Rbc Set (49). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.